The Gut-Hormone Connection: How Your Microbiome Shapes Oestrogen, PMS and Perimenopause
If you've ever wondered why gut symptoms and hormonal symptoms so often show up in the same person, sometimes the same week, there's a genuine biological reason and it has a name: the estrobolome. This isn't a fringe wellness concept. It's an active area of gastroenterology and endocrinology research with a real, well-described mechanism behind it alongside some areas where the evidence is still developing and deserves an honest "we don't fully know yet."
What is the estrobolome?
The estrobolome refers to the specific collection of gut bacteria and their genes that are capable of metabolising oestrogen. After your liver processes oestrogen and packages it for elimination via bile into your gut, certain gut bacteria produce an enzyme called beta-glucuronidase that can essentially unpack that oestrogen again, reactivating it so it gets reabsorbed back into circulation rather than excreted. This is a normal physiological process, not a malfunction, but how much of it happens depends heavily on which bacteria are present and how active they are (Hu et al., 2023). The foundational research identifying and validating these specific bacterial enzymes was published in the Journal of Biological Chemistry in 2019, confirming that gut microbial beta-glucuronidase enzymes directly reactivate oestrogens as a genuine component of hormone regulation (Ervin et al., 2019).
Why this matters for PMS, PCOS and perimenopause
Because this recirculation process directly affects how much oestrogen stays in circulation versus how much leaves the body, an imbalanced gut microbiome can shift the overall oestrogen load your body is working with. This has made the estrobolome a genuine area of interest for conditions where oestrogen balance plays a role, including PMS, PCOS, endometriosis and the hormonal fluctuations of perimenopause. It's also a two-way relationship: oestrogen itself influences which bacteria thrive in your gut, meaning the hormone and the microbiome are constantly shaping each other rather than one simply driving the other (Hu et al., 2023).
What happens to this system at perimenopause and menopause
Interestingly, the research here doesn't point in a single simple direction. A large population study published in mSystems, analysing stool samples from over 2,000 participants, found that postmenopausal women had measurably lower levels of the bacterial beta-glucuronidase enzyme than premenopausal women, alongside broader shifts in gut bacterial diversity and composition (Peters et al., 2022). This tells us the gut-hormone relationship isn't just about "too much recirculation equals too much oestrogen." As oestrogen naturally declines through perimenopause and menopause, the gut microbiome itself shifts in response, which is part of why digestive symptoms so often change noticeably during this transition, not purely a coincidence of ageing.
Where the evidence is genuinely still developing
It's worth being honest about where the research hasn't caught up to the popular claims yet. The estrobolome's role in hormone-driven cancers, particularly breast cancer, gets discussed confidently in a lot of wellness content, but a thorough 2025 review in the International Journal of Cancer found that evidence from actual case-control studies was heterogeneous and showed limited consistency with the specific bacterial targets the estrobolome theory would predict (Larnder, Manges & Murphy, 2025). The researchers concluded that broader shifts in overall gut ecology, rather than these specific estrogen-metabolising bacteria alone, may turn out to be more relevant. This is the kind of nuance that's worth knowing rather than glossing over: the core mechanism (gut bacteria can reactivate oestrogen) is solid, but extending that mechanism confidently into specific disease outcomes is, for now, still an open question in several areas.
What this means practically
Supporting gut microbial diversity and balance is a genuinely evidence-grounded part of supporting hormonal health not because it's a guaranteed fix for any one condition but because the gut and your hormone systems are demonstrably intertwined in both directions. This is exactly why a hormone-focused treatment plan that ignores gut health, or a gut-focused plan that ignores hormonal status, tends to leave something on the table.
Frequently Asked Questions
What is the estrobolome?
The estrobolome is the collection of gut bacteria capable of producing an enzyme called beta-glucuronidase, which reactivates oestrogen that your liver has packaged for elimination, allowing it to recirculate back into your body rather than being excreted.
Can gut health affect PMS or PCOS?
There's a genuine, well-described mechanism connecting gut bacteria to circulating oestrogen levels, which makes gut health a legitimate consideration alongside other factors in PMS and PCOS, though it's one piece of a multifactorial picture rather than the sole cause.
Does menopause change your gut microbiome?
Yes. Research has found measurable shifts in gut bacterial diversity and a reduction in the bacterial enzyme that recirculates oestrogen following menopause, suggesting the gut and hormone systems continue to influence each other through this transition.
Is the gut-hormone connection linked to breast cancer risk?
This is an active area of research, but a 2025 review found the evidence from human studies so far has been inconsistent, and broader gut ecology changes may matter more than the specific estrobolome mechanism alone. This is genuinely still being worked out, not settled science.
Curious how this connects to your own symptoms?
If your hormonal symptoms and digestive symptoms seem to move together, that's worth exploring as one connected picture. Book your free 15-minute Discovery Call (https://earthflow-health.au4.cliniko.com/bookings) and let's look at what's going on for you.
References
1. Hu, S., Ding, Q., Zhang, W., Kang, M., Ma, J., & Zhao, L. (2023). Gut microbial beta-glucuronidase: A vital regulator in female estrogen metabolism. Gut Microbes, 15(1), 2236749. https://pmc.ncbi.nlm.nih.gov/articles/PMC10416750/
2. Ervin, S. M., Li, H., Lim, L., Roberts, L. R., Liang, X., Mani, S., & Redinbo, M. R. (2019). Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. Journal of Biological Chemistry, 294(49), 18586–18599.
3. Peters, B. A., Lin, J., Qi, Q., Usyk, M., Isasi, C. R., Mossavar-Rahmani, Y., Derby, C. A., Santoro, N., Perreira, K. M., Daviglus, M. L., Kominiarek, M. A., Cai, J., Knight, R., Burk, R. D., & Kaplan, R. C. (2022). Menopause is associated with an altered gut microbiome and estrobolome, with implications for adverse cardiometabolic risk in the Hispanic Community Health Study/Study of Latinos. mSystems, 7(3), e0027322. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239235/
4. Larnder, A. H., Manges, A. R., & Murphy, R. A. (2025). The estrobolome: Estrogen-metabolizing pathways of the gut microbiome and their relation to breast cancer. International Journal of Cancer, 157(4), 599–613. https://pmc.ncbi.nlm.nih.gov/articles/PMC12178105/